# Impact of Emicizumab on Activated Clotting Time Using the i-STAT Alinity Analyzer

> **NCT05856903** · — · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 15 (estimated)

## Conditions studied

- Hemophilia A

## Interventions

- **DIAGNOSTIC_TEST:** ACT

## Key facts

- **NCT ID:** NCT05856903
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-12
- **Primary completion:** 2025-03
- **Final completion:** 2025-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05856903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05856903, "Impact of Emicizumab on Activated Clotting Time Using the i-STAT Alinity Analyzer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05856903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*